Article Details
Retrieved on: 2021-10-27 00:21:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
BOSTON, MA / ACCESSWIRE / October 26, 2021 /Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here